Commentary by Helen Kourlas PharmD, Pharmacology Section Editor
On October 16th the FDA announced the approval of raltegravir (Isentress®) for the treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents. The …
Commentary by Judith Brenner MD, Associate Program Director, NYU Internal Medicine Residency Program
Published early online in NEJM comes the CORONA study “Rosuvastatin in Older Patients with Systolic Heart Failure”. In this trial, …
Welcome to our Grand Rounds Series. Each week, we plan to post a summary of the week’s Medicine Grand Rounds lecture. The summaries are reviewed and approved by the grand rounds …
Commentary by Mary Vouyiouklis MD, Fellow, and Ann Danoff MD, Director, Division of Endocrinology, Diabetes and Metabolism, NYU Medical Center
Welcome to Case 6 of our special diabetes series intended to highlight the essentials …
Case by: Alana Choy-Shan, Chief Resident
Commentary by William Slater MD, Associate Professor of Medicine, Division of Cardiology
Following Thanksgiving dinner, a 36 year-old healthy man developed palpitations and heart racing. He was …
Case presentation by Shrujal Baxi MD, Chief Resident
Welcome to the monthly posting of our NYU Department of Medicine’s Clinical Pathology Conference. Use the links below to review the case and the …
Commentary by Henry Tran, MDÂ
Hip fractures in the elderly are associated with a very high morbidity and mortality. Often a fracture can be the prelude to an accelerated decline in the health and …
Welcome to our new Grand Rounds Series. Each week, we plan to post a summary of the week’s Medicine Grand Rounds lecture. The summaries are reviewed and approved by the grand …